Forte Biosciences (FBRX)
(Delayed Data from NSDQ)
$10.30 USD
-0.28 (-2.65%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $10.27 -0.03 (-0.29%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Forte Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
FBRX 10.30 -0.28(-2.65%)
Will FBRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FBRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBRX
All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy
Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why
FBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going
Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for FBRX
Sixteen new option listings on July 23rd
FEDERATED HERMES, INC. Acquires 1,072,233 Shares in Forte Biosciences Inc
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Forte Biosciences Announces Public Offering of Shares